CJC-1295 (no DAC) / Ipamorelin peptide blend: 5 mg of each component, 10 mg total per vial. For laboratory studies of peptide signaling. Published component research does not establish the properties of this combined formulation.
For laboratory research only. Not for human or veterinary use.
Reviews
There are no reviews yet.